How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
By not modernizing legacy systems and software, labs risk incurring hidden costs
How clinical laboratories should prepare for the next wave of oversight in the new year
We explain the fundamentals of hazardous waste generation, classification, and management
If clinical lab managers instruct marketing personnel to engage in kickback practices, they also could be held legally accountable
The $14.6 billion bust by federal prosecutors shows gaps that every laboratory should monitor
Washington State’s Department of Health details how its medical testing site program meets federal standards
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant